Hexcel (NYSE:HXL) reported higher second-quarter sales, margins and cash flow as commercial aircraft production rates increased, led by demand on wide-body programs including the Airbus A350 and Boeing 787. Second-quarter sales totaled $529 million, up 8% from the prior-year period, while adjusted
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Huntington Ingalls Industries (NYSE:HII) reported second-quarter 2026 sales of $3.4 billion and diluted earnings per share of $5.27, as higher volumes at its shipbuilding operations helped drive revenue growth and prompted the company to raise its full-year shipbuilding outlook. Chief Executive Off
Investing.com -- Chevron Corporation (NYSE: CVX) reported second-quarter earnings before the open on Friday, topping consensus expectations.
Same-store sales continue to rise.
Ahead of its second-quarter earnings report, McDonald's is in a correction, but risk-tolerant dividend investors may want to sink their teeth into the stock.
The supplier to major automakers, including BMW, Volkswagen and Ford slashed its medium-term sales expectations against a darkening backdrop for the industry.
More of the same is exactly what investors want from the surprisingly rewarding dividend payer.
This Dividend King continues to prove it's more than worthy of the title.
SLB’s second quarter results were met with a significant positive market reaction, as the company’s performance exceeded Wall Street’s expectations despite a year-on-year revenue decline. Management credited broad-based international growth and a rebound in North American operations as primary contributors to the quarter. CEO Olivier Le Peuch highlighted “higher offshore activity in Latin America, Europe, Africa, and Asia,” as well as increased demand in U.S. land for production and recovery sol
The tech rebound has legs. Stock futures were rising early Friday as the technology sector looked set to end a bad July on a positive note despite disappointing earnings from Apple. S&P 500 futures rose 0.
Positive figures from two key areas could send the stock higher.
The automaker put a date on autonomy, and its latest results raised guidance again. The stock's price barely acknowledges either.
Floor & Decor (NYSE:FND) reported second-quarter fiscal 2026 adjusted diluted earnings per share of $0.58, unchanged from a year earlier, as the company managed expenses and generated free cash flow despite continued softness in large discretionary flooring projects. Total sales increased 3% ye
Endeavour Silver (NYSE:EXK) reported higher production, record metal sales and a sharp increase in mine operating cash flow during the second quarter, as the Terronera mine continued ramping up and the Kolpa operation achieved higher throughput. Chief Executive Officer Dan Dickson said the company
July 31 (Reuters) - European shares hit a record high on Friday, powered by improving investor appetite for tech shares globally, while corporate earnings buoyed markets through a week of central bank
Walt Disney’s stock is down about 0.1% in July, after posting declines in May and June.
Sony hiked its profit forecasts for the current year on Friday, helped by the Japanese consumer electronics giant's video games division and the weak yen.Sony on Friday indicated that it has sufficient components to meet planned production levels for its PlayStation 5 during the current fiscal year.
EMCOR Group (NYSE:EME) reported record second-quarter revenue, operating income and remaining performance obligations, driven by strong demand in data centers, institutional projects, manufacturing and industrial work, and other end markets. The company also raised its full-year 2026 revenue and ear
Diana Shipping (NYSE:DSX) reported higher second-quarter revenue, earnings and adjusted EBITDA as improved charter rates, lower interest expense and gains on equity securities supported profitability. For the quarter ended June 30, 2026, time charter revenue rose to $57.3 million from $54.7 million
Morningstar maintained an $850 fair value estimate for META, implying a 58% upside from current levels.
Dolby Laboratories (NYSE:DLB) reported third-quarter fiscal 2026 revenue of $305 million, within its prior guidance range, as strength in Dolby Atmos, Dolby Vision and imaging patents was partly offset by deal timing and foundational audio revenue. Non-GAAP earnings per share were $0.69, slightly a
By Rae Wee SINGAPORE, July 31 (Reuters) - Asian markets rallied hard with Wall Street on Friday as South Korea's battered market made a record comeback, stirring hopes that a recent rout in AI-related
Coinbase reports record Coinbase One subscriptions and expanding revenue streams beyond Bitcoin, while navigating Clarity Act hurdles and intensifying competition.
AXT Inc (AXTI) posts historic Q2 2026 results with revenue up 164% year-over-year, driven by explosive indium phosphide growth for AI data centers.
Cigna Group (NYSE:CI) raised its full-year 2026 adjusted earnings outlook after reporting second-quarter results that management said exceeded expectations in both its Evernorth health services business and Cigna Healthcare insurance segment. The company reported second-quarter total revenue of $71
Core Laboratories (NYSE:CLB) reported second-quarter 2026 revenue of $124.6 million, up more than 2% from the prior quarter but down 4% from a year earlier, as stronger completion-product sales partly offset disruptions to its service business from conflicts in the Middle East and Russia-Ukraine. C
Reddit Inc (RDDT) posts 61% revenue growth and $1M per employee milestone, but navigates search volatility and US DAU declines.
BigBear.ai accelerates growth with record contract wins, expanded GenAI capabilities, and a strategic push into M&A despite widening adjusted EBITDA losses.
Roblox Corp (RBLX) reports strong user growth and cash flow, yet faces near-term monetization headwinds from algorithm changes and AI investments, leading to withdrawn full-year guidance.
Tempus AI Inc (TEM) reports strong Q2 2026 results with record revenue, FDA approval for xT CDx, and a major BioNTech partnership, driving a raised outlook for 25% annual growth.